Park Square has placed Mark Namchuk, Ph.D. as executive director of therapeutics translation at Harvard Medical School.
| less than a minute read
Mark Namchuk, Ph.D. named Harvard Medical School Executive Director of Therapeutics Translation
Harvard Medical School has named Mark Namchuk, PhD, a former pharmaceutical R&D executive with a background in immunology and bioorganic chemistry, as executive director of therapeutics translation. Namchuk, who joins Harvard Medical School from Alkermes, will assume his role on Jan. 2.

/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-09-29-16-59-13-899-6abbee61460fb9469a25b973.jpg)
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-10-21-12-53-31-969-6ad8b5cb057433a11d528afb.jpg)
/Passle/58a5cb8db00e8110e83aa395/SearchServiceImages/2026-10-19-20-59-27-876-6ad684af780cfbe7accbf179.jpg)
